News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gamma Pharmaceuticals Gets Purchase Orders From Market Leading Pharmacy and Supermarket Chains With Market Value of Up to $3.5 Million



6/4/2009 11:28:04 AM

LAS VEGAS, NV--(Marketwire - June 04, 2009) -

Gamma Pharmaceuticals Inc. (OTCBB: GMPM) has been issued Purchase Orders from market leading retail pharmacy and supermarket chains in the American Southwest. Gamma estimates the Purchase Orders should lead to incremental retail market value of $3,500,000 in the first 12 months. This is Gamma's fourth significant order in six months, demonstrating the strong momentum Gamma is gaining in the market. Peter Cunningham, Gamma's CEO, commented, "Gamma's expanding retail profile and distribution resources are significantly strengthened with the receipt of our new POs. They strengthen our existing and effective network of distributor resources and direct to retail systems in this important region, particularly in Texas." He continued, "Retail chains are very supportive of Gamma's aggressive promotional programs for the territory and are taking product immediately."

The new purchase orders represent a significant increase in Gamma's market share. Gamma's brands are cited by consumers as being equal to or better than similar offerings from Pfizer, Johnson & Johnson and Bayer Xetra, BAYG.X.

Gamma Pharmaceuticals Inc. is a marketing and product formulation company. The Company creates, registers and brands innovative product lines, including Nutritional Supplements, Personal Care Products and Over-The-Counter (OTC) pharmaceuticals. At present, Gamma manufactures in North America, and distributes in the United States and China. Gamma's products utilize a proprietary "Gel Delivery Technology®," offering one of the most innovative gel product forms; offering consumers a more pleasant experience with product forms that absorb more rapidly, are more convenient and taste great. Market categories Gamma targets are growing as rapidly as 60% per year.

Gamma master brands include: Brilliant Choice®, a range of children's vitamins, nutritional supplements and immune boosters, and Savvy®, a range of adult vitamins, nutritional supplements and immune boosters. Youth targeted products are sold as Jugular® Energy - "Go for the Jugular"™; and iceDROP Instant Hand Sanitizer™ (Beijing). In addition, Gamma has developed formulas and strategies for Metabolic Syndrome and Diabetes Type II, Stress reduction, Cognition, Well being, Menopause Symptoms, and Personal Care Products. Gamma also develops and manufactures house brands for major retailers. At this time, Gamma holds licenses for 9 SKUs in China.

Forward-Looking Statements: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.


Contact:
Gamma Pharmaceuticals Inc.
Joe Cunningham
Office: 702 989 5262
Direct: 651 204 2048


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES